Elanco Animal Health Incorporated (ELAN)

USD 8.68

(0.7%)

Revenue Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual revenue in 2023 was 4.41 Billion USD , down -0.02% from previous year.
Elanco Animal Health Incorporated's latest quarterly revenue in 2024 Q2 was 1.18 Billion USD , down -1.74% from previous quarter.
Elanco Animal Health Incorporated reported a annual revenue of 4.41 Billion USD in annual revenue 2022, down -7.28% from previous year.
Elanco Animal Health Incorporated reported a annual revenue of 4.76 Billion USD in annual revenue 2021, up 45.57% from previous year.
Elanco Animal Health Incorporated reported a quarterly revenue of 1.18 Billion USD for 2024 Q2, down -1.74% from previous quarter.
Elanco Animal Health Incorporated reported a quarterly revenue of 1.05 Billion USD for 2023 Q2, down -15.91% from previous quarter.

Annual Revenue Chart of Elanco Animal Health Incorporated (2023 - 2015)

Historical Annual Revenue of Elanco Animal Health Incorporated (2023 - 2015)

Year	Revenue	Revenue Growth
2023	4.41 Billion USD	-0.02%
2022	4.41 Billion USD	-7.28%
2021	4.76 Billion USD	45.57%
2020	3.27 Billion USD	6.59%
2019	3.07 Billion USD	0.14%
2018	3.06 Billion USD	6.15%
2017	2.88 Billion USD	-0.84%
2016	2.91 Billion USD	0.15%
2015	2.9 Billion USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	1.2 Billion USD	16.43%
2024 Q2	1.18 Billion USD	-1.74%
2023 Q2	1.05 Billion USD	-15.91%
2023 Q4	1.03 Billion USD	-3.09%
2023 FY	4.41 Billion USD	-0.02%
2023 Q3	1.06 Billion USD	1.04%
2023 Q1	1.25 Billion USD	27.23%
2022 Q4	988 Million USD	-3.89%
2022 FY	4.41 Billion USD	-7.28%
2022 Q3	1.02 Billion USD	-12.66%
2022 Q2	1.17 Billion USD	-3.92%
2022 Q1	1.22 Billion USD	10.06%
2021 Q3	1.13 Billion USD	-11.57%
2021 FY	4.76 Billion USD	45.57%
2021 Q4	1.11 Billion USD	-1.59%
2021 Q1	1.24 Billion USD	8.98%
2021 Q2	1.27 Billion USD	2.98%
2020 Q3	889.6 Million USD	51.73%
2020 Q4	1.13 Billion USD	28.11%
2020 FY	3.27 Billion USD	6.59%
2020 Q1	657.7 Million USD	-16.43%
2020 Q2	586.3 Million USD	-10.86%
2019 Q4	787 Million USD	2.04%
2019 Q3	771.3 Million USD	-1.32%
2019 Q2	781.6 Million USD	6.91%
2019 FY	3.07 Billion USD	0.14%
2019 Q1	731.1 Million USD	-8.53%
2018 Q4	799.3 Million USD	5.02%
2018 FY	3.06 Billion USD	6.15%
2018 Q3	761.1 Million USD	-1.18%
2018 Q2	770.2 Million USD	4.62%
2018 Q1	736.2 Million USD	-2.4%
2017 Q1	718.8 Million USD	0.0%
2017 Q4	754.3 Million USD	8.21%
2017 Q2	718.8 Million USD	0.0%
2017 Q3	697.1 Million USD	-3.02%
2017 FY	2.88 Billion USD	-0.84%
2016 FY	2.91 Billion USD	0.15%
2015 FY	2.9 Billion USD	0.0%

Peer Revenue Comparison of Elanco Animal Health Incorporated

Name	Revenue	Revenue Difference
Amneal Pharmaceuticals, Inc.	2.39 Billion USD	-84.533%
Bausch Health Companies Inc.	8.75 Billion USD	49.56%
Catalent, Inc.	4.38 Billion USD	-0.822%
Emergent BioSolutions Inc.	1.04 Billion USD	-320.947%
Perrigo Company plc	4.65 Billion USD	5.125%
Teva Pharmaceutical Industries Limited	15.84 Billion USD	72.125%
Zoetis Inc.	8.54 Billion USD	48.303%